Background: Venous thromboembolism (VTE) is a common source of perioperative
morbidity and mortality. Objective: These evidence-based guidelines from the American …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Seventh American College of Chest Physicians Conference on Antithrombotic and …

Objective: To provide an update to the “Surviving Sepsis Campaign Guidelines for
Management of Severe Sepsis and Septic Shock,” last published in 2008. Design: A …

Objective: To provide an update to the original Surviving Sepsis Campaign clinical
management guidelines,“Surviving Sepsis Campaign Guidelines for Management of Severe …

This article discusses the prevention of venous thromboembolism (VTE) and is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence …

Background Heparin-induced thrombocytopenia, defined by the presence of heparin-
dependent IgG antibodies, typically occurs five or more days after the start of heparin …

The implications of a particular embolic event depend upon the extent of obstruction of the
crosssectional area of the pulmonary arterial bed as well as upon the presence or absence …

• Design: either prospective cohort studies or control groups of randomized trials•
Interventions: no prophylaxis used

Heparin-induced thrombocytopenia (HIT) is an uncommon but potentially devastating
complication of anticoagulation with unfractionated heparin (UFH) or low-molecular-weight …

The rationale for prophylaxis of venous thromboembolism (VfE) is based on the clinically
silent nature of the disease, the relatively high prevalence among hospitahzed patients, and …